06:38:44 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandNorge
ListaOAX Equities
SektorHälsovård
IndustriBioteknik
Aqua Bio Technology är ett norskt bolag verksamma inom kosmetikabranschen. Bolaget utvecklar, tillverkar och kommersialiserar ingredienser som används inom ett flertal kosmetiska produkter världen över. Störst verksamhet återfinns inom lösningar för hudvårdsprodukter. Merparten av bolagets produkter säljs på en global marknad via diverse distributörer. Bolaget grundades 2004 och har sitt huvudkontor i Lysaker.

Kalender

2021-08-25 Kvartalsrapport 2021-Q2
2021-06-09 Årsstämma 2021
2021-04-30 Bokslutskommuniké 2020
2020-09-11 Extra Bolagsstämma 2020
2020-08-26 Kvartalsrapport 2020-Q2
2020-06-11 Ordinarie utdelning ABT 0.00 NOK
2020-06-10 Årsstämma 2020
2020-04-15 Bokslutskommuniké 2019
2019-08-28 Kvartalsrapport 2019-Q2
2019-06-06 Ordinarie utdelning ABT 0.00 NOK
2019-06-05 Årsstämma 2019
2019-04-24 Bokslutskommuniké 2018
2019-01-07 Extra Bolagsstämma 2019
2018-08-22 Kvartalsrapport 2018-Q2
2018-05-30 Årsstämma 2018
2018-02-21 Bokslutskommuniké 2017
2017-08-16 Kvartalsrapport 2017-Q2
2017-06-08 Ordinarie utdelning ABT 1.00 NOK
2017-06-07 Årsstämma 2017
2017-02-15 Bokslutskommuniké 2016
2016-11-18 Bonusutdelning ABT 1
2016-11-17 Extra Bolagsstämma 2016
2016-11-17 Kvartalsrapport 2016-Q3
2016-08-17 Kvartalsrapport 2016-Q2
2016-06-09 Ordinarie utdelning ABT 1.50 NOK
2016-06-08 Årsstämma 2016
2016-05-11 Kvartalsrapport 2016-Q1
2016-02-10 Bokslutskommuniké 2015
2015-11-18 Kvartalsrapport 2015-Q3
2015-08-19 Kvartalsrapport 2015-Q2
2015-06-04 Ordinarie utdelning ABT 1.00 NOK
2015-06-03 Årsstämma 2015
2015-05-13 Kvartalsrapport 2015-Q1
2015-02-11 Bokslutskommuniké 2014
2014-11-26 Kvartalsrapport 2014-Q3
2014-08-20 Kvartalsrapport 2014-Q2
2014-06-11 Årsstämma 2014
2014-05-21 Kvartalsrapport 2014-Q1
2014-02-12 Bokslutskommuniké 2013
2013-11-27 Kvartalsrapport 2013-Q3
2013-08-21 Kvartalsrapport 2013-Q2
2013-06-13 Kapitalmarknadsdag 2013
2013-06-12 Ordinarie utdelning
2013-06-11 Årsstämma 2013
2013-05-22 Kvartalsrapport 2013-Q1
2013-02-13 Bokslutskommuniké 2012
2012-11-27 Kvartalsrapport 2012-Q3
2012-08-28 Kvartalsrapport 2012-Q2
2012-06-14 Årsstämma 2012
2012-05-23 Kvartalsrapport 2012-Q1
2012-02-17 Bokslutskommuniké 2011
2011-11-30 Kvartalsrapport 2011-Q3
2011-08-29 Kvartalsrapport 2011-Q2
2011-06-17 Ordinarie utdelning
2011-06-16 Årsstämma 2011
2011-05-30 Kvartalsrapport 2011-Q1
2011-02-18 Bokslutskommuniké 2010
2021-02-12 15:26:26
12.2.2021 15:26:24 CET | Aqua Bio Technology ASA | Inside information

Aqua Bio Technology ASA (ABT) has today signed an distribution agreement with
Galaxa Pharma Aps [https://www.galaxapharma.com/] (Galaxa). The agreement grants
Galaxa distribution rights for Denmark for the certified organic skincare line
Moana Skincare. ABT has previously announced its acquisition of all rights to
Moana Skincare [https://newsweb.oslobors.no/message/513213].

Galaxa has since 2014 been commercially active in Denmark as a representative of
various foreign producers, with sales through drugstores (Matas), pharmacies and
its own web shop [https://cosmage.dk/]. Today Galaxa has product series within
skincare and anti-aging, medical device approved cannabis products and eyelash &
brow products based on active Ingredients from eye medicine. Galaxa has since
2014 established a distribution model that covers approx. 200 stores.

"We are pleased to have entered into a distribution agreement with Galaxa.
Galaxa has an interesting and very forward-looking business model and we believe
that this agreement can give our companies synergies beyond the distribution
agreement," says Espen Kvale, CEO of Aqua Bio Technology ASA.

"We are looking forward to the new partnership with Aqua Bio Technology ASA.
From the outset, our mission has been to identify and introduce new innovative
products and treatments to promote health and wellbeing for the Nordic
consumers. Moana Skincare, as a certified organic skincare line, is therefore
well-suited for our customers and market, " says Lone Henriksen, CEO of Galaxa
Pharma Aps.

For further information, please contact Espen Kvale, CEO, telephone +47 916 28
092

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
effective and they provide the cosmetics industry with natural alternatives to
traditional ingredients. ABT is also marketing and distributing natural skin
care products developed by partners towards consumers and professional users.
ABT's focus on commercialization and development of natural ingredients and
natural skin care products has been, and will continue to be, an important part
of the company's strategy going forward. Aqua Bio Technology is listed on
Euronext Expand.

This information is subject to the disclosure requirements pursuant to section
5-12 of the Norwegian Securities Trading Act.









DISCLAIMER

This information is subject of the disclosure requirements pursuant to section
of 5-12 of the Norwegian Securities Trading Act.

CONTACTS

* Espen Kvale, CEO, +47 916 28 092, espen.kvale@aquabiotech.no

ABOUT AQUA BIO TECHNOLOGY ASA

Aqua Bio Technology (ABT) is developing and commercializing sustainable
biotechnology for use in skin care products. ABT's cosmetics ingredients are
highly effective and they provide the cosmetics industry with natural
alternatives to traditional ingredients. ABT is also marketing and distributing
natural skin care products developed by partners towards consumers and
professional users. Aqua Bio Technology is listed on Euronext Expand.

ATTACHMENTS

* Download announcement as PDF.pdf
[https://kommunikasjon.ntb.no/ir-files/17847556/314/380/Download%20announceme
nt%20as%20PDF.pdf]